Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019

IMPORTANCE: Children of all ages appear susceptible to severe acute respiratory syndrome coronavirus 2 infection. To support pediatric clinical studies for investigational treatments of coronavirus disease 2019 (COVID-19), pediatric-specific dosing is required. OBJECTIVE: To define pediatric-specifi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Pediatr
Autors principals: Maharaj, Anil R., Wu, Huali, Hornik, Christoph P., Balevic, Stephen J., Hornik, Chi D., Smith, P. Brian, Gonzalez, Daniel, Zimmerman, Kanecia O., Benjamin, Daniel K., Cohen-Wolkowiez, Michael
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7275264/
https://ncbi.nlm.nih.gov/pubmed/32501511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.2422
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars